Hims Hers Health Inc (HIMS)
Official siteHEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $4.62B
Last updated: Nov 17, 2026 at 11:06 AM ET
Hims Hers Health Inc (HIMS) Earnings: Report Dates and Results
Hims Hers Health (HIMS) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, Hims Hers Health reported EPS of $0.03, below the $0.07 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
HIMS has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 50.0% above the $0.08 reported for the quarter ended Dec 31, 2025.
HIMS Earnings Call
The latest HIMS earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 23 quarters below that had an estimate, HIMS beat 11 and missed 12. Revenue for the quarter ended Sep 30, 2026 was $890.37M, up 48.6% from $598.98M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.03 | $0.07 | -$0.05 - $0.20 | -57.14% | Miss | -50.0% | 11 | 0 up, 2 down | Nov 9, 2026 | $890.37M |
| Jun 30, 2026 | -$0.10 | -$0.07 | N/A | -42.86% | Miss | -134.5% | 2 | 0 up, 0 down | Aug 10, 2026 | $753.21M |
| Mar 31, 2026 | -$0.40 | $0.03 | -$0.04 - $0.15 | N/A | N/A | -300.0% | 11 | 0 up, 0 down | May 11, 2026 | $608.10M |
| Dec 31, 2025 | $0.08 | $0.04 | -$0.04 - $0.15 | +100.00% | Beat | -27.3% | 12 | 0 up, 8 down | Feb 23, 2026 | $617.82M |
| Sep 30, 2025 | $0.06 | $0.10 | $0.03 - $0.16 | -40.00% | Miss | -81.3% | 13 | 0 up, 10 down | Nov 3, 2025 | $598.98M |
| Jun 30, 2025 | $0.29 | $0.23 | $0.20 - $0.27 | +26.09% | Beat | +383.3% | 4 | 1 up, 3 down | Aug 4, 2025 | $544.83M |
| Mar 31, 2025 | $0.20 | $0.12 | N/A | +66.67% | Beat | +300.0% | 6 | 1 up, 0 down | May 5, 2025 | $586.01M |
| Dec 31, 2024 | $0.11 | $0.22 | $0.16 - $0.28 | -49.43% | Miss | +1000.0% | 4 | 0 up, 0 down | Feb 24, 2025 | $481.14M |
| Sep 30, 2024 | $0.32 | $0.05 | -$0.04 - $0.10 | +540.00% | Beat | N/A | 11 | 1 up, 0 down | Nov 4, 2024 | $401.56M |
| Jun 30, 2024 | $0.06 | $0.05 | $0.02 - $0.06 | +20.00% | Beat | N/A | 11 | 0 up, 0 down | Aug 5, 2024 | $315.65M |
| Mar 31, 2024 | $0.05 | $0.01 | -$0.04 - $0.03 | +400.00% | Beat | +66.7% | 10 | 0 up, 0 down | May 6, 2024 | $278.17M |
| Dec 31, 2023 | $0.01 | -$0.02 | -$0.04 - -$0.01 | +150.00% | Beat | N/A | 7 | 0 up, 0 down | Feb 26, 2024 | $246.62M |
| Sep 30, 2023 | -$0.04 | -$0.03 | -$0.04 - -$0.02 | -33.33% | Miss | N/A | 8 | 0 up, 0 down | Nov 6, 2023 | $226.70M |
| Jun 30, 2023 | -$0.03 | -$0.04 | -$0.10 - -$0.03 | +25.00% | Beat | N/A | 7 | 0 up, 0 down | Aug 7, 2023 | $207.91M |
| Mar 31, 2023 | $0.03 | $0.02 | N/A | +50.00% | Beat | N/A | 7 | 2 up, 0 down | May 8, 2023 | $190.77M |
| Dec 31, 2022 | -$0.05 | -$0.07 | -$0.11 - -$0.05 | +28.57% | Beat | N/A | 6 | 0 up, 0 down | Feb 27, 2023 | $167.20M |
| Sep 30, 2022 | -$0.09 | -$0.06 | N/A | -50.00% | Miss | N/A | 5 | 1 up, 0 down | Nov 7, 2022 | $144.84M |
| Jun 30, 2022 | -$0.10 | -$0.09 | -$0.11 - -$0.05 | -11.11% | Miss | N/A | 6 | 1 up, 0 down | Aug 8, 2022 | $113.56M |
| Mar 31, 2022 | -$0.08 | -$0.06 | -$0.11 - -$0.05 | -33.33% | Miss | N/A | 4 | 0 up, 0 down | May 9, 2022 | $101.31M |
| Dec 31, 2021 | -$0.15 | -$0.07 | -$0.10 - -$0.06 | -114.29% | Miss | N/A | 4 | N/A | Feb 22, 2022 | $84.70M |
| Sep 30, 2021 | -$0.10 | -$0.06 | -$0.08 - -$0.04 | -66.67% | Miss | N/A | 3 | N/A | Nov 10, 2021 | $74.17M |
| Jun 30, 2021 | -$0.09 | -$0.06 | -$0.16 - -$0.06 | -50.00% | Miss | N/A | 3 | N/A | Aug 11, 2021 | $60.69M |
| Mar 31, 2021 | -$0.28 | -$0.07 | -$0.20 - -$0.06 | -300.00% | Miss | -660.0% | 4 | N/A | May 17, 2021 | $52.31M |
| Dec 31, 2020 | -$0.07 | -$0.16 | N/A | +56.25% | Beat | -333.3% | N/A | N/A | Mar 18, 2021 | $41.47M |
| Sep 30, 2020 | -$0.06 | N/A | N/A | N/A | N/A | -385.5% | N/A | N/A | Nov 12, 2020 | $41.32M |
| Jun 30, 2020 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2020 | $35.90M |
| Mar 31, 2020 | $0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2020 | $30.06M |
| Dec 31, 2019 | $0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 27, 2020 | $24.77M |
| Sep 30, 2019 | $0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2019 | N/A |
| Jun 30, 2019 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 29, 2019 | N/A |
| Mar 31, 2019 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2019 | $18.05M |
| Dec 31, 2018 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2019 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.63, up 16.7% from the year before. It was -$0.27 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.63 | +16.7% |
| Dec 31, 2024 | $0.54 | N/A |
| Dec 31, 2023 | -$0.03 | N/A |
| Dec 31, 2022 | -$0.32 | N/A |
| Dec 31, 2021 | -$0.62 | N/A |
| Dec 31, 2020 | -$0.15 | N/A |
| Dec 31, 2019 | -$0.46 | N/A |
| Dec 31, 2018 | -$0.27 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 10,000 words across 10 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 10,235 | 10 | |
| 2026Q2 | Jun 30, 2026 | 9,593 | 11 | |
| 2026Q1 | Mar 31, 2026 | 10,115 | 12 | |
| 2025Q4 | Dec 31, 2025 | 10,134 | 12 | |
| 2025Q3 | Sep 30, 2025 | 9,463 | 11 | |
| 2025Q2 | Jun 30, 2025 | 8,910 | 14 | |
| 2025Q1 | Mar 31, 2025 | 9,322 | 13 | |
| 2024Q4 | Dec 31, 2024 | 7,874 | 9 |
2026Q3 Earnings Call
Opening remarks
William Newby Director of Investor Relations Good afternoon, everyone, and welcome to the Hims & Hers Health Third Quarter 2026 Earnings Call. On the call with me today is Andrew Dudum, our Co-Founder and Chief Executive Officer; Yemi Okupe, our Chief Financial Officer; and Mo Elshenawy, our Chief Technology Officer. Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on, among other things, our current market, competitors, and regulatory expectations, and are subject to risks and uncertainties that could cause actual results to vary materially. We take no obligation to update publicly any forward-looking statement after this call, whether as a result of new information, future events, changes in assumptions, or otherwise. The risks, uncertainties, and other factors that could cause actual results to differ from our forward-looking statements are described in our earnings release and SEC filings. Please see our recent earnings release and most recently filed 10-K and 10-Q reports for a discussion of these risk factors as they relate to forward-looking statements. In today's presentation, we also have certain non-GAAP financial measures. We refer you to the reconciliation tables to the most directly comparable GAAP financial measures contained in today's press release. You can find this information, as well as a link to today's webcast, at investors.hims.com. After the call, this webcast will be archived on the website for 12 months. And with that, I will turn the call over to Andrew.
Andrew Dudum Co-Founder and CEO Thanks, Bill. Good afternoon, everyone, and thank you for joining us. This was a quarter of real progress toward building a company that we believe has never existed before: an everyday digital health platform that tens of millions of people rely on, not for a single treatment, but for the whole of how they take care of themselves. Before we turn to the quarter, I want to spend a few minutes on the thesis behind everything we're building because it explains both the results you're seeing today and the decisions we're making for the years ahead. Our conviction is simple. In health care, whoever owns the customer relationship wins. That's easy to say and very hard to do. Most companies in our industry build around a treatment, a condition, or a moment in time. They capture a single transaction, but then lose the thread. Customers want something different. They want a place that knows them, stays with them, and grows with them as their needs change.
Frequently Asked Questions About HIMS
When is Hims Hers Health's next earnings date?
Hims Hers Health's next earnings report is expected for Feb 22, 2027.
Did HIMS beat earnings estimates last quarter?
No. Hims Hers Health reported EPS of $0.03 for the quarter ended Sep 30, 2026, below the $0.07 estimate by 57.14%.
What EPS do analysts expect from HIMS next quarter?
The consensus EPS estimate for Hims Hers Health for the quarter ending Dec 31, 2026 is $0.12 from 15 analysts, with estimates from -$0.02 to $0.33.
How often does HIMS beat earnings estimates?
Hims Hers Health beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +67.92%.
HIMS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors